Am Heart J

1. HOPPER I, Marwick TH, Wolfe R, Amerena J, et al
   STAREE-HEART: a randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants.
   Am Heart J. 2025 Jun 12:S0002-8703(25)00193-0. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   

   
   Am J Cardiol

2. SEPHIEN A, Girgis JG, Reljic T, Dayto DC, et al
   Efficacy and Safety of Different Combinations of Add-on Diuretic Therapy in Acute Heart Failure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
   Am J Cardiol. 2025 Aug 26:S0002-9149(25)00505.
   

   >> Share

   
   
3. ONO R, Falcao LM
   Coronary Artery Disease in Heart Failure with Preserved Ejection Fraction.
   Am J Cardiol. 2025 Aug 25:S0002-9149(25)00499.
   

   >> Share

   
   

   
   Cardiovasc Res

4. HASTINGS MH, Zhou Q, Wu C, Shabani P, et al
   Cardiac ageing: from hallmarks to therapeutic opportunities.
   Cardiovasc Res. 2025;121:1474-1488.
   

   >> Share

   
   

   
   Chest

5. DRURY KA, Seeto JA, Hong S, Wewege MA, et al
   Failure to report sex-specific risk factors in heart failure with preserved ejection fraction research: a scoping review.
   Chest. 2025 Aug 26:S0012-3692(25)05116-5. doi: 10.1016/j.chest.2025.07.4082.
   

   >> Share

   
   

   
   Circ Res

6. VENKATESAN T, Toumpourleka M, Niewiadomska M, Farhat K, et al
   Vagal Stimulation Rescues HFpEF by Altering Cardiac Resident Macrophage Function.
   Circ Res. 2025;137:664-681.
   

   >> Share

   
   

   
   Clin Cardiol

7. KHAN M, Suribhatla R, Spencer J, Daniel N, et al
   Prevalence of Pulmonary Hypertension in Individuals With Heart Failure: A Systematic Review and Meta-Analysis.
   Clin Cardiol. 2025;48:e70197.
   

   >> Share

   
   

   
   Eur Heart J

8. DOCHERTY KF, Heywood B, Bayes-Genis A, Campbell RT, et al
   Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failure.
   Eur Heart J. 2025 Aug 29:ehaf675. doi: 10.1093.
   

   >> Share

   
   
9. MORA-AYESTARAN N, Ochoa JP, Gomez-Gonzalez C, Navarro-Penalver M, et al
   Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure.
   Eur Heart J. 2025 Aug 29:ehaf605. doi: 10.1093.
   

   >> Share

   
   

   
   Eur J Heart Fail

10. PRAKASH ES
    Letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-AHF): A prospective, randomized, mechanistic study'.
    Eur J Heart Fail. 2025 Jul 23. doi: 10.1002/ejhf.3790.
    

    >> Share

    
    
11. PETRIE MC, Cherney DZI, Desai AS, Testani JM, et al
    Sodium zirconium cyclosilicate, hyperkalaemia, and spironolactone optimization in heart failure with reduced ejection fraction: The REALIZE-K open-label run-in phase.
    Eur J Heart Fail. 2025 Aug 20. doi: 10.1002/ejhf.3787.
    

    >> Share

    
    
12. ANSARI RAMANDI MM, van Melle JP, Voors AA
    Reply to the letter regarding the article 'Heart failure in patients with a systemic right ventricle: A multicentre study with long-term follow-up'.
    Eur J Heart Fail. 2025 Jul 14. doi: 10.1002/ejhf.3750.
    

    >> Share

    
    
13. BEGGS SAS, Petrie MC, Wright S, Connelly DT, et al
    Why do people with heart failure die? Rationale and design of the RHYTHM-HF study.
    Eur J Heart Fail. 2025 Aug 29. doi: 10.1002/ejhf.70014.
    

    >> Share

    
    
14. BIEGUS J, Zymlinski R, Ponikowski P
    Reply to 'Is sodium chloride supplementation ready for clinical practice in acute heart failure?'.
    Eur J Heart Fail. 2025 Jul 21. doi: 10.1002/ejhf.3773.
    

    >> Share

    
    
15. KEMPF T, Geller W, Fuge J, Sandu MA, et al
    Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure.
    Eur J Heart Fail. 2025 Jul 21. doi: 10.1002/ejhf.3789.
    

    >> Share

    
    
16. BIEGUS J, Iwanek G, Ponikowski P
    Reply to 'Sodium chloride supplementation in acute heart failure: A closer look at SOLVRED-AHF'.
    Eur J Heart Fail. 2025 Jul 15. doi: 10.1002/ejhf.3771.
    

    >> Share

    
    
17. MASUDA Y, Yamamoto I
    Is sodium chloride supplementation ready for clinical practice in acute heart failure? Letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-
    Eur J Heart Fail. 2025 Jul 21. doi: 10.1002/ejhf.3765.
    

    >> Share

    
    
18. OKAZAKI T, Yaegashi Y
    Sodium chloride supplementation in acute heart failure: A closer look at SOLVRED-AHF. Letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-A
    Eur J Heart Fail. 2025 Jul 15. doi: 10.1002/ejhf.3767.
    

    >> Share

    
    
19. ALMESNED MA, van Essen BJ, Emmens JE, Tromp J, et al
    Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction.
    Eur J Heart Fail. 2025 Aug 6. doi: 10.1002/ejhf.3788.
    

    >> Share

    
    
20. HARM T, Keren A, Borst O
    Parvovirus B19 - more than a bystander in the prognosis of non-ischaemic heart failure.
    Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.70008.
    

    >> Share

    
    
21. JEAN SS, Lai CC
    Letter regarding the article 'Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease'.
    Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.3769.
    

    >> Share

    
    
22. WEGERMANN K, Fudim M
    Reply to the letter regarding the article 'Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease'.
    Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.3777.
    

    >> Share

    
    
23. BURGOS LM, Baro Vila R, Goyeneche A, Costabel JP, et al
    Residual congestion defined by HFA-ESC multiparametric criteria and 90-day outcomes in worsening heart failure.
    Eur J Heart Fail. 2025 Aug 11. doi: 10.1002/ejhf.70004.
    

    >> Share

    
    
24. BHATTI T
    Letter regarding the article 'Heart failure in patients with a systemic right ventricle: A multicentre study with long-term follow-up'.
    Eur J Heart Fail. 2025 Jul 14. doi: 10.1002/ejhf.3747.
    

    >> Share

    
    
25. SAKATA Y, Nochioka K, Yasuda S, Shimokawa H, et al
    Reply to the letter regarding the article 'Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure'.
    Eur J Heart Fail. 2025 Jul 10. doi: 10.1002/ejhf.3740.
    

    >> Share

    
    
26. FAUCHIER L, Lochon L, Lenormand T, Pierre B, et al
    Cardiovascular outcomes with tirzepatide in heart failure with preserved ejection fraction associated with obesity.
    Eur J Heart Fail. 2025 Aug 29. doi: 10.1002/ejhf.70012.
    

    >> Share

    
    
27. ZHANG H, Gao W
    Beyond pharmacotherapy: Addressing system-level barriers in women's heart failure care. Letter regarding the article 'Sex-based differences in heart failure management and outcomes: Insights from the French-DataHF cohort'.
    Eur J Heart Fail. 2025 Jul 23. doi: 10.1002/ejhf.3791.
    

    >> Share

    
    

    
    Heart

28. BEREZIN A
    Carbohydrate antigen 125: promising diagnostic biomarker in heart failure with preserved ejection fraction.
    Heart. 2025 Aug 28:heartjnl-2025-326900. doi: 10.1136/heartjnl-2025-326900.
    

    >> Share

    
    
29. DE JUAN BAGUDA J, Severo Sanchez A, de la Espriella R, Valero-Masa MJ, et al
    Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis.
    Heart. 2025 Aug 28:heartjnl-2025-326053. doi: 10.1136/heartjnl-2025-326053.
    

    >> Share

    
    

    
    Int J Cardiol

30. MONZO L, Girerd N
    Decoding the inflammatory-metabolic code: machine learning potential for outcome prediction in heart failure with diabetes.
    Int J Cardiol. 2025 Aug 27:133828. doi: 10.1016/j.ijcard.2025.133828.
    

    >> Share

    
    

    
    J Am Coll Cardiol

31. HALLER PM, Melloni GEM, Berg DD, Kamanu FK, et al
    A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07028.
    

    >> Share

    
    
32. OSTROMINSKI JW, Hojbjerg Lassen MC, Butt JH, Claggett BL, et al
    Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials.
    J Am Coll Cardiol. 2025 Aug 23:S0735-1097(25)07398.
    

    >> Share

    
    

    
    J Cardiol

33. LUO S
    Letter to the editor: Impact of congestive heart failure on early fluid administration and mortality in patients with sepsis.
    J Cardiol. 2025 Aug 26:S0914-5087(25)00214-X. doi: 10.1016/j.jjcc.2025.
    

    >> Share

    
    

    
    Lancet

34. WALSH M, Collister D, Gallagher M, Mark PB, et al
    Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial.
    Lancet. 2025;406:695-704.
    

    >> Share

    
    

    
    N Engl J Med

35. BAVENDIEK U, Grosshennig A, Schwab J, Berliner D, et al
    Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2415471.
    

    >> Share

    
    

    
    PLoS Med

36. MANNE-GOEHLER J, Venter WDF, Ali MK, Franco JVA, et al
    Cardiovascular-kidney-metabolic syndrome: A new frontier or simple rebranding?
    PLoS Med. 2025;22:e1004723.
    

    >> Share

    
    

    
    PLoS One

37. SHEN X, Li W, Jiang X, Wen H, et al
    TGFBR1 gene silencing attenuates cardiomyopathy in the HFpEF mouse model.
    PLoS One. 2025;20:e0328981.
    

    >> Share

    
    
38. TATEISHI R, Miyazaki S, Yamao K, Negishi M, et al
    Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol.
    PLoS One. 2025;20:e0321604.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share